Quantum 90 is a trade name for bumetanide, a diuretic medication [1]. It is used to treat fluid retention (edema) in patients with congestive heart failure, liver disease, or kidney disorders [1]. Bumetanide works by helping the kidneys remove excess salt and water from the body [1].
What is Bumetanide and How Does It Work?
Bumetanide is a loop diuretic, meaning it acts on the loop of Henle in the kidneys to inhibit the reabsorption of sodium, potassium, and chloride. This action leads to increased excretion of these electrolytes and water, thereby reducing fluid volume in the body [1]. It is prescribed to manage edema associated with conditions like congestive heart failure, liver cirrhosis, and renal disease [1].
What Other Conditions Does Bumetanide Treat?
Beyond edema, bumetanide is also used to treat high blood pressure (hypertension) in some cases, although it is not typically a first-line treatment for this condition [1]. Its primary role remains in managing fluid overload.
How is Bumetanide Administered and What Are Common Dosages?
Bumetanide is available in oral tablet form and as an injectable solution for intravenous or intramuscular administration [1]. Oral dosages for adults typically range from 0.5 mg to 2 mg once or twice daily, with adjustments made based on patient response [1]. The injectable form is used when oral administration is not feasible or for more rapid effect, with dosages adjusted accordingly [1].
What Are the Potential Side Effects of Bumetanide?
Common side effects of bumetanide can include dizziness, lightheadedness, muscle cramps, weakness, and nausea [1]. More serious side effects, though less common, may involve dehydration, electrolyte imbalances (such as low potassium or magnesium levels), hearing loss or ringing in the ears (tinnitus), and a drop in blood pressure [1].
Are There Any Safety Concerns or Precautions for Bumetanide?
Patients with certain medical conditions, such as kidney problems, liver disease, or a history of gout, should use bumetanide with caution [1]. Close monitoring of kidney function and electrolyte levels is often recommended during treatment [1]. It is also important to inform a healthcare provider about all other medications being taken, as bumetanide can interact with other drugs [1].
When Does the Patent for Bumetanide Expire?
Bumetanide is a well-established medication with generic versions available. As such, the original patents protecting its composition and use have long expired [2]. Information regarding specific patent expiry dates for older drugs can be found on resources like DrugPatentWatch.com [2].
Who Manufactures Bumetanide and Its Generics?
Multiple pharmaceutical companies manufacture generic versions of bumetanide [1]. These manufacturers offer the drug under various brand names and as generic bumetanide.
How Does Bumetanide Compare to Other Diuretics?
Bumetanide is classified as a loop diuretic, similar to furosemide and torsemide. Loop diuretics are generally more potent than thiazide diuretics (like hydrochlorothiazide) or potassium-sparing diuretics (like spironolactone) [1]. The choice of diuretic depends on the specific condition being treated and the patient's individual needs and response [1].
Where Can I Find More Information on Bumetanide Patents?
Detailed information on drug patents, including expiry dates and any related litigation, can be accessed through specialized databases and resources such as DrugPatentWatch.com [2].
What Clinical Data Supports the Use of Bumetanide?
Clinical studies have demonstrated the efficacy of bumetanide in reducing fluid overload and improving symptoms in patients with various edematous conditions [1]. Its mechanism of action and effectiveness in managing fluid balance are well-documented in medical literature [1].
What Are Patient Concerns Regarding Bumetanide?
Patients may have concerns about the frequency of urination, potential electrolyte imbalances, and interactions with other medications. Discussing these concerns with a healthcare provider is essential for managing treatment effectively [1].
What Are the Regulatory Approvals for Bumetanide?
Bumetanide has received approval from regulatory bodies such as the U.S. Food and Drug Administration (FDA) for its indicated uses [1].
Sources:
[1] https://www.drugs.com/bumetanide.html
[2] https://drugpatentwatch.com/